自引率: 3.2%
被引量: 2429
通过率: 暂无数据
审稿周期: 暂无数据
版面费用: 暂无数据
国人发稿量: 暂无数据
投稿须知/期刊简介:
Reviews in Endocrine and Metabolic Disorders is be an international journal dedicated to students clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field. The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice. The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area. The individual papers are brief overviews of the latest developments with insight into the basic aspects of the disease and translation into clinical aspects. Thus the student academic clinician and practicing clinician will be able to understand the disease process and apply this knowledge to his or her area of interest. Selected readings and other essential references will enable the reader to investigate a particular topic in a more in-depth approach.
期刊描述简介:
Reviews in Endocrine and Metabolic Disorders is be an international journal dedicated to students clinicians and researchers involved in the broad area of endocrinology and metabolism. This field of medicine and biology is rapidly advancing and a major challenge is to keep abreast of the advances in the field. The mission of this review journal is to keep those interested individuals informed of all the latest exciting advancements that are essential to their research or clinical practice. The format of this review journal differs from existing journals. Each of the quarterly issues covers a specific topic. Ten to twelve articles will be published by world leaders in this area. The individual papers are brief overviews of the latest developments with insight into the basic aspects of the disease and translation into clinical aspects. Thus the student academic clinician and practicing clinician will be able to understand the disease process and apply this knowledge to his or her area of interest. Selected readings and other essential references will enable the reader to investigate a particular topic in a more in-depth approach.
-
Drug induced hypoprolactinemia.
被引量：- 发表：1970
-
Isolated hypoprolactinemia: The rarest of the rare?
被引量：- 发表：1970
-
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review.
Oral hormone replacement therapy has been and continues to be the cornerstone of adrenocortical insufficiency management. However, the introduction of continuous subcutaneous hydrocortisone infusion (CSHI) shows great potential for advancing the management of adrenocortical insufficiency. It resembles the circadian rhythm of physiological cortisol secretion and was shown to have a promising outcome in terms of quality of life (QOL) and clinical outcomes in the literature. We conducted a systematic search strategy including MEDLINE, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and the online trials registers at ClinicalTrials.gov without geographic restrictions. Research investigations where self-reported quality of life (QOL) was assessed as a variable in adult individuals with confirmed adrenal disease, treated by CSHI, and results were presented in English. All articles included were published between 2014 and 2023, even though we had no timeframe limitations in our inclusion criteria. A total of six studies were included, with 63 subjects enrolled, and the average age was 40 years, a study showed a significant reduction in the average total daily dose of HC from 47.5 mg to 31.4 mg on CSHI, while other two studies estimated a reduction in the hospitalization rate due to adrenal crisis from 2.6 to 1.3 admissions per year on CSHI. Most of the studies on subjective well-being and quality of life have shown significant improvement. Overall, CSHI shows great potential as a treatment method for Adrenal insufficiency. It improves the quality of life and lowers hospitalization rates, resulting in increased patient satisfaction and acceptance. Additional comprehensive research is necessary to strengthen these discoveries, gain a deeper understanding of the effectiveness and safety of this treatment approach, and provide guidance for medical practitioners.
被引量：- 发表：1970
-
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy.
Secondary adrenal insufficiency (SAI) is an endocrine disorder due to impaired secretion of ACTH resulting from any disease affecting the pituitary gland. Glucocorticoid replacement therapy is mandatory to ensure patient survival, haemodynamic stability, and quality of life. In fact, a correct dose adjustement is mandatory due to the fact that inappropriately low doses expose patients to hypoadrenal crisis, while inappropriately high doses contribute to glucose metabolic and cardiovascular deterioration. This review analyses the current evidence from available publications on the epidemiology and aetiology of SAI and examines the association between glucocorticoid replacement therapy and glucometabolic and cardiovascular effects.
被引量：- 发表：1970
-
Correction to: Diagnostic and therapeutic use of oral micronized progesterone in endocrinology.
被引量：- 发表：1970
